 Electronic File Wrappers |  Electronic Patent Documents |  Paper Patent Documents | Current as of: June, 1999
|  and Services |
| DF | CLASS NOTES | |
| 200 | DF | NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.) |
| 201 | DF | .~ Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.) |
| 202 | DF | .~ Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material) |
| 203 | DF | .~ Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material) |
| 204 | DF | .~.~ Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material) |
| 205 | DF | .~ Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.) |
| 206 | DF | .~.~ Organic sulfur or nitrogen containing material used in the process, or product thereof |
| 207 | DF | .~.~ Esterification used in the process, or product thereof |
| 208 | DF | .~.~ Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.) |
| 209 | DF | .~.~.~ Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof |
| 210 | DF | .~ Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.) |
| 211 | DF | .~.~ Polymerization or product thereof (e.g., dimer rosin, etc.) |
| 212 | DF | .~.~.~ Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.) |
| 213 | DF | .~.~ Boron or phosphorus containing material used in the process, or product thereof |
| 214 | DF | .~.~ Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.) |
| 215 | DF | .~.~ Esterification of rosin or derivative via carboxyl group, or product thereof |
| 216 | DF | .~.~.~ Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.) |
| 217 | DF | .~.~.~ Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.) |
| 218 | DF | .~.~.~ Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.) |
| 219 | DF | .~.~ Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.) |
| 220 | DF | .~.~.~ The sulfur, selenium, or tellurium containing material is inorganic |
| 221 | DF | .~.~ Nitrogen containing material used in the process, or product thereof |
| 222 | DF | .~.~.~ The nitrogen containing material is inorganic |
| 223 | DF | .~.~ Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.) |
| 224 | DF | .~.~ Metal containing material used to form salts of rosin acids, or product thereof |
| 225 | DF | .~.~.~ Alkali metal containing material (i.e., Li, Na, K, Rb or Cs) |
| 226 | DF | .~.~ Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.) |
| 227 | DF | .~.~.~ Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.) |
| 228 | DF | .~.~ Purification process or product thereof |
| 229 | DF | .~.~.~ Immiscible solvents used in the process, or product thereof |
| 230 | DF | .~ Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.) |
| 231 | DF | .~.~ Nitrogen containing material used in the process, or product thereof |
| 232 | DF | .~.~ Esterification of tall oil acids, or product thereof |
| 233 | DF | .~.~ Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof |
| 300 | DF | PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES |
| 301 | DF | .~ Thymopoietin or Lipotropin; related peptides |
| 302 | DF | .~ Endorphin and Enkephalin; related peptides |
| 303 | DF | .~ Insulin; related peptides |
| 304 | DF | .~.~ Metal complexes, e.g., Zn-insulin, etc. |
| 305 | DF | .~.~ Isolation or purification |
| 306 | DF | .~ Corticotropin (ATCH); related peptides |
| 307 | DF | .~ Calcitonin; related peptides |
| 308 | DF | .~ Glucagon; related peptides |
| 309 | DF | .~ Secretin or gastrin; related peptides |
| 310 | DF | .~ Gramicidin or Tyrocidin; related peptides |
| 311 | DF | .~ Somatostatin (SRIF); related peptides |
| 312 | DF | .~ Melanotropin (MSH) or eledoisin; related peptides |
| 313 | DF | .~ Lutenizing hormone releasing factor (LRF); related peptides |
| 314 | DF | .~ Bradykinin; kallidin; related peptides |
| 315 | DF | .~ Oxytocin; vasopressin; related peptides |
| 316 | DF | .~ Angiotensin; related peptides |
| 317 | DF | .~ Cyclic peptides |
| 318 | DF | .~.~ The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid |
| 319 | DF | .~.~.~ Polymyxin; related peptides |
| 320 | DF | .~.~ Bacitracin; related peptides |
| 321 | DF | .~.~ Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides |
| 322 | DF | .~ Peptides containing saccharide radicals, e.g., bleomycins, etc. |
| 323 | DF | .~ Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc. |
| 324 | DF | .~ 25 or more amino acid residues in defined sequence |
| 325 | DF | .~ 24 amino acid residues in defined sequence |
| 326 | DF | .~ 15 to 23 amino acid residues in defined sequence |
| 327 | DF | .~ 11 to 14 amino acid residues in defined sequence |
| 328 | DF | .~ 8 to 10 amino acid residues in defined sequence |
| 329 | DF | .~ 6 to 7 amino acid residues in defined sequence |
| 330 | DF | .~ 4 to 5 amino acid residues in defined sequence |
| 331 | DF | .~ Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc. |
| 332 | DF | .~ Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc. |
| 333 | DF | .~ Synthesis of peptides |
| 334 | DF | .~.~ Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc. |
| 335 | DF | .~.~ Protecting or removing protective groups, e.g., carboxyl group protection, etc. |
| 336 | DF | .~.~.~ Of side chain or sulfur containing group |
| 337 | DF | .~.~.~ Of amino group |
| 338 | DF | .~.~ Solution phase synthesis |
| 339 | DF | .~.~.~ Segment condensation, e.g., Ugi condensation, etc. |
| 340 | DF | .~.~.~ With phosphorus containing material |
| 341 | DF | .~.~.~ With use of carbonimide or imidiazole |
| 342 | DF | .~.~.~ Mixed anhydride synthesis |
| 343 | DF | .~.~ By hydrolysis |
| 344 | DF | .~ Separation or purification |
| 345 | DF | .~ Chemical aftertreatment, e.g., acylation, methylation, etc. |
| 350 | DF | PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES |
| 351 | DF | .~ Lymphokines, e.g., interferons, interlukins, etc. |
| 352 | DF | .~ Phosphoproteins, e.g., phosvitin, vitellogenin, etc. |
| 353 | DF | .~ Scleroproteins, e.g., fibroin, elastin, silk, etc. |
| 354 | DF | .~.~ Gelatin |
| 355 | DF | .~.~.~ Separation, purification or synthesis |
| 356 | DF | .~.~ Collagen |
| 357 | DF | .~.~ Keratin |
| 358 | DF | .~ Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc. |
| 359 | DF | .~ Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc. |
| 360 | DF | .~ Casein or caseinate |
| 361 | DF | .~.~ Separation, purification or synthesis |
| 362 | DF | .~ Albumin |
| 363 | DF | .~.~ Serum albumin, e.g., BSA, HSA, etc. |
| 364 | DF | .~.~.~ Separation, purification or synthesis |
| 365 | DF | .~.~ Lactalbumin, e.g., milk source, etc. |
| 366 | DF | .~.~.~ Separation, purification or synthesis |
| 367 | DF | .~.~ Ovalalbumin, e.g., avidin, conalbumins, etc. |
| 368 | DF | .~.~.~ Separation, purification or synthesis |
| 369 | DF | .~.~ Separation, purification or synthesis |
| 370 | DF | .~ Plant proteins, e.g., derived from legumes, algae or lichens, etc. |
| 371 | DF | .~.~ Derived from fungi, e.g., yeasts, mushroom, etc. |
| 372 | DF | .~.~ Derived from grain, e.g., prolamines, etc. |
| 373 | DF | .~.~.~ Zein |
| 374 | DF | .~.~.~ Gluten or gliadin |
| 375 | DF | .~.~.~ Derived from wheat |
| 376 | DF | .~.~.~ Derived from corn |
| 377 | DF | .~.~ Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc. |
| 378 | DF | .~.~.~ Derived from soybean |
| 379 | DF | .~.~ Derived from leafy green plants, e.g., alfalfa pollen, etc. |
| 380 | DF | .~ Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. |
| 381 | DF | .~.~ Blood coagulation factors and fibrin, e.g., thromboplastin, etc. |
| 382 | DF | .~.~.~ Fibrin or fibrin intermediates, e.g., fibrinogen, etc. |
| 383 | DF | .~.~.~ Blood coagulation factor VIII, AHF |
| 384 | DF | .~.~.~ Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor |
| 385 | DF | .~.~ Hemoglobins or globins |
| 386 | DF | .~.~ Globulins |
| 387.1 | DF | .~.~.~ Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed |
| 387.2 | DF | .~.~.~.~ Anti-idiotypic |
| 387.3 | DF | .~.~.~.~ Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.) |
| 387.5 | DF | .~.~.~.~ Binds oligosaccharide structure |
| 387.7 | DF | .~.~.~.~ Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
| 387.9 | DF | .~.~.~.~ Binds specifically-identified amino acid sequence |
| 388.1 | DF | .~.~.~.~ Monoclonal |
| 388.15 | DF | .~.~.~.~.~ Human |
| 388.2 | DF | .~.~.~.~.~ Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) |
| 388.21 | DF | .~.~.~.~.~.~ Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.) |
| 388.22 | DF | .~.~.~.~.~.~ Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.) |
| 388.23 | DF | .~.~.~.~.~.~ Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.) |
| 388.24 | DF | .~.~.~.~.~.~ Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.) |
| 388.25 | DF | .~.~.~.~.~.~ Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| 388.26 | DF | .~.~.~.~.~.~ Binds enzyme |
| 388.3 | DF | .~.~.~.~.~.~ Binds virus or component or product thereof (e.g., virus-associated antigen, etc.) |
| 388.35 | DF | .~.~.~.~.~.~.~ Binds retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.) |
| 388.4 | DF | .~.~.~.~.~.~ Binds bacterium or similar microorganism or component or product thereof (e.g., Stretococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.) |
| 388.5 | DF | .~.~.~.~.~.~ Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.) |
| 388.6 | DF | .~.~.~.~.~.~ Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.) |
| 388.7 | DF | .~.~.~.~.~.~ Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) |
| 388.73 | DF | .~.~.~.~.~.~.~ Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.) |
| 388.75 | DF | .~.~.~.~.~.~.~.~ Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.) |
| 388.8 | DF | .~.~.~.~.~.~ Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.) |
| 388.85 | DF | .~.~.~.~.~.~.~ Binds antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.) |
| 388.9 | DF | .~.~.~.~.~ Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
| 389.1 | DF | .~.~.~.~ Polyclonal antibody or immunogloblin of identified binding specificity |
| 389.2 | DF | .~.~.~.~.~ Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.) |
| 389.3 | DF | .~.~.~.~.~ Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| 389.4 | DF | .~.~.~.~.~ Binds virus or component or product thereof (e.g., virus-associated antigen, etc.) |
| 389.5 | DF | .~.~.~.~.~ Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.) |
| 389.6 | DF | .~.~.~.~.~ Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.) |
| 389.7 | DF | .~.~.~.~.~ Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.) |
| 389.8 | DF | .~.~.~.~.~ Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
| 390.1 | DF | .~.~.~.~ Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.) |
| 390.5 | DF | .~.~.~.~ Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.) |
| 391.1 | DF | .~.~.~ Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.) |
| 391.3 | DF | .~.~.~.~ Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound |
| 391.5 | DF | .~.~.~.~.~ Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent |
| 391.7 | DF | .~.~.~.~ Conjugated to a cytotoxic agent, drug, or other biologically-active substance |
| 391.9 | DF | .~.~.~.~.~ Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent |
| 392 | DF | .~.~.~ Alpha globulins, e.g., ceruloplastin, haptoglobins, etc. |
| 393 | DF | .~.~.~.~ Antithrombin III |
| 394 | DF | .~.~.~ Beta globulins, e.g., transferrin, etc. |
| 395 | DF | .~ Glycoprotein, e.g., mucins proteoglycans, etc. |
| 396 | DF | .~.~ Lectins, e.g., concanavalin, hemagglutinin, etc. |
| 397 | DF | .~.~ Glycoprotein hormones |
| 398 | DF | .~.~.~ Gonadatropins |
| 399 | DF | .~ Hormones, e.g., prolactin, thymosin, growth factors, etc. |
| 400 | DF | .~ Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc. |
| 401 | DF | .~.~ Cytochromes, e.g., chlorophyl, orgotein, etc. |
| 402 | DF | .~ Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc. |
| 403 | DF | .~.~ Protein is identified as an antigen, e.g., immunogenic carriers, etc. |
| 404 | DF | .~.~.~ Sulfur containing reactant |
| 405 | DF | .~.~.~ Nitrogen containing reactant |
| 406 | DF | .~.~.~ Oxygen containing reactant |
| 407 | DF | .~.~ Hydrolysis of protein |
| 408 | DF | .~.~ Sulfur containing reactant |
| 409 | DF | .~.~ Nitrogen containing reactant |
| 410 | DF | .~.~ Oxygen containing reactant |
| 411 | DF | .~.~.~ Oxygen containing is saccharide |
| 412 | DF | .~ Separation or purification |
| 413 | DF | .~.~ Immunological separation or affinity chromatography |
| 414 | DF | .~.~ Ultra filtration or osmosis |
| 415 | DF | .~.~ Selective absorbtion, e.g., Ca phosphate sorbents, etc. |
| 416 | DF | .~.~.~ Ion exchange |
| 417 | DF | .~.~.~ Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc. |
| 418 | DF | .~.~ Precipitation |
| 419 | DF | .~.~.~ With added material |
| 420 | DF | .~.~.~.~ Inorganic |
| 421 | DF | .~.~.~.~ Polymeric, e.g., polyethylene glycol, etc. |
| 422 | DF | .~.~ Solvent extraction |
| 423 | DF | .~.~.~ Oxygenated material |
| 424 | DF | .~.~.~.~ Alcohol |
| 425 | DF | .~.~.~.~ Carboxyl containing |
| 426 | DF | .~.~.~ Hydrocarbon or halogenated hydrocarbon |
| 427 | DF | .~.~ Physical treatment |
| 500 | DF | LIGNINS OR DERIVATIVES |
| 501 | DF | .~ Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof |
| 502 | DF | .~ Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof |
| 503 | DF | .~ Hydrogenation of a lignin or lignin containing substance, or product thereof |
| 504 | DF | .~ Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof |
| 505 | DF | .~ Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof |
| 506 | DF | .~ Heavy metal, aluminum, silicon or phosphorus containing |
| 507 | DF | .~ Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof |
| ****************************** | ||
| CROSS-REFERENCE ART COLLECTIONS | ||
| ****************************** | ||
| 800 | DF | ANTIHYPERTENSIVE PEPTIDES |
| 801 | DF | PEPTIDE SWEETNERS |
| 802 | DF | CHROMOGENIC OR LUMINESCENT PEPTIDES |
| 806 | DF | ANTIGENIC PEPTIDES OR PROTEINS |
| 807 | DF | HAPTEN CONJUGATED WITH PEPTIDE OR PROTEIN |
| 808 | DF | MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC. |
| 809 | DF | .~ Fused cells, e.g., hybridoma, etc. |
| 810 | DF | CARRIER - BOUND OR IMMOBILIZED PEPTIDES OR PROTEINS AND THE PREPARATION THEREOF, E.G., BIOLOGICAL CELL OR CELL FRAGMENT AS CARRIER, ETC. |
| 811 | DF | .~ Peptides or proteins is immobilized on, or in, an inorganic carrier |
| 812 | DF | .~ Peptides or proteins is immobilized on, or in, an organic carrier |
| 813 | DF | .~.~ Carrier is a saccharide |
| 814 | DF | .~.~.~ Cellulose or derivatives thereof |
| 815 | DF | .~.~ Carrier is a synthetic polymer |
| 816 | DF | .~.~.~ Attached to the carrier via a bridging agent |
| 817 | DF | .~.~.~ Entrapped within the carrier, e.g., gel, hollow fibre, etc. |
| 820 | DF | PROTEINS FROM MICRO-ORGANISMS |
| 821 | DF | .~ Separation of nucleic acid |
| 822 | DF | .~ Protozoa |
| 823 | DF | .~ Lower fungi, e.g., mold, etc. |
| 824 | DF | .~.~ Yeasts |
| 825 | DF | .~ Bacteria |
| 826 | DF | .~ Viruses |
| 827 | DF | PROTEINS FROM MAMMALS OR BIRDS |
| 828 | DF | .~ Cancer |
| 829 | DF | .~ Blood |
| 830 | DF | .~.~ Plasma; serum |
| 831 | DF | .~.~.~ Cohn fractions |
| 832 | DF | .~ Milk; colostrum |
| 833 | DF | .~ Whey; cheese |
| 834 | DF | .~ Urine; urinary system |
| 835 | DF | .~.~ Kidney |
| 836 | DF | .~ Mucus; mucous glands; bursa; arthral fluid; spinal fluid |
| 837 | DF | .~ Lymph; lymph-glands; thymus |
| 838 | DF | .~ Marrow; spleen |
| 839 | DF | .~ Nerves; brain |
| 840 | DF | .~ Bones; tendons; teeth; cartilage |
| 841 | DF | .~ Muscles; heart |
| 842 | DF | .~ Skin; hair; nails; sebaceous glands; cerumen |
| 843 | DF | .~ Digestive system |
| 844 | DF | .~.~ Stomach; intestine |
| 845 | DF | .~.~ Pancreas |
| 846 | DF | .~.~ Liver |
| 847 | DF | .~.~ Bile |
| 848 | DF | .~ Lungs |
| 849 | DF | .~ Eyes; vessels; umbilical cord |
| 850 | DF | .~ Reproductive organs or embryos |
| 851 | DF | .~.~ Placenta; amniotic fluid |
| 852 | DF | .~.~ Sperm |
| 853 | DF | .~.~.~ Ovary; eggs; embryos |
| 854 | DF | .~ Glands |
| 855 | DF | PROTEINS FROM ANIMALS OTHER THAN MAMMALS OR BIRDS |
| 856 | DF | .~ Snakes; venom |
| 857 | DF | .~ Fish; fish eggs; shell fish; crustacea |
| 858 | DF | .~ Insects; venom |
| 859 | DF | WASTE, WASTE MATERIAL, REFUSE OR SLUDGE, E.G., EFFLUENTS, FECAL MATTER, ETC. |
| 860 | DF | RENIN INHIBITORS |
| 861 | DF | INVOLVING IgG3, IgG4, IgA, or IgY |
| 862 | DF | INVOLVING IgE or IgD |
| 863 | DF | INVOLVING IgM |
| 864 | DF | .~ Monoclonal |
| 865 | DF | .~.~ Human |
| 866 | DF | INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT, (e.g., F(ab)'2, Fab', Fab, Fv, Fc, heavy chain, light chain, etc.) |
| 867 | DF | INVOLVING IMMUNOGLOBULIN OR ANTIBODY PRODUCED VIA RECOMBINANT DNA TECHNOLOGY |
| 868 | DF | INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCE |